Impact of pneumonia on hyperactive delirium in end-stage lung cancer patients
Purpose Patients with incurable lung cancer often receive palliative care. Hyperactive delirium is a burden not only for the patient’s family but also for caregivers. There are no reports describing the risk factors for delirium among lung cancer patients. The present study investigated the frequenc...
Gespeichert in:
| Veröffentlicht in: | Supportive care in cancer 2013-01, Vol.21 (1), p.281-285 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 285 |
|---|---|
| container_issue | 1 |
| container_start_page | 281 |
| container_title | Supportive care in cancer |
| container_volume | 21 |
| creator | Suzuki, Hidekazu Hirashima, Tomonori Kobayashi, Masashi Okamoto, Norio Matsuura, Yuka Tamiya, Motohiro Morishita, Naoko Okafuji, Kohei Shiroyama, Takayuki Morimura, Osamu Morita, Satomu Kawase, Ichiro |
| description | Purpose
Patients with incurable lung cancer often receive palliative care. Hyperactive delirium is a burden not only for the patient’s family but also for caregivers. There are no reports describing the risk factors for delirium among lung cancer patients. The present study investigated the frequency of incidence and risk factors for hyperactive delirium among end-stage lung cancer patients.
Methods
Patients who died of lung cancer in our institute from January 2010 to December 2010 were retrospectively investigated. Information was obtained from medical records, and patients who developed hyperactive delirium (delirium group, group D) were compared with patients who did not (control group, group C) based on clinical and laboratory data.
Results
A total of 146 patients (median age, 70 years; 80 % male) died of lung cancer. Thirty-one (21.2 %) patients developed hyperactive delirium. Sex (
P
= 0.0093) and pneumonia (
P
= 0.023) were statistically significant variables in univariate analysis. Pneumonia occurred in 27.4 % of all patients. The incidence of pneumonia was 45.2 % in group D and 22 % in group C. Only pneumonia (odds ratio, 2.89; 95 % confidence interval, 1.22–6.85;
P
= 0.016) was identified as a significant factor for predicting hyperactive delirium in multivariate analysis.
Conclusions
Pneumonia was identified as a significant risk factor for the development of hyperactive delirium among end-stage lung cancer patients. |
| doi_str_mv | 10.1007/s00520-012-1522-8 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_1221858393</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A336843896</galeid><sourcerecordid>A336843896</sourcerecordid><originalsourceid>FETCH-LOGICAL-c505t-bfe7b4cd21934d36e4b61bdc1a6d91e79f73272142417ee1c7a20b6215021b4e3</originalsourceid><addsrcrecordid>eNp1kUtr3TAQhUVpaG7T_oBuiqCbbpRo9LSXIfQRSMkmXQtZHt8q2LIr2YX8--py0yctWgxovnOYmUPIK-DnwLm9KJxrwRkHwUALwZonZAdKSmalbJ-SHW8VMCW1PiXPS7nnHKzV4hk5FcICb5TakU_X0-LDSueBLgm3aU7R0znRLw8L5tqI35D2OMYct4nGRDH1rKx-j3Tc0p4GnwJmuvg1YlrLC3Iy-LHgy8d6Rj6_f3d39ZHd3H64vrq8YUFzvbJuQNup0AtopeqlQdUZ6PoA3vQtoG0HK4UVoIQCiwjBesE7I0BzAZ1CeUbeHn2XPH_dsKxuiiXgOPqE81YcCAGNbmQrK_rmL_R-3nKq01XKmHotbuwvau9HdDEN81q3P5i6SylNo2TTmkqd_4Oqr8cphjnhEOv_HwI4CkKeS8k4uCXHyecHB9wdInTHCF2N0B0idE3VvH4ceOsm7H8qfmRWAXEESm2lPebfNvqv63cq9aNS</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1266433067</pqid></control><display><type>article</type><title>Impact of pneumonia on hyperactive delirium in end-stage lung cancer patients</title><source>MEDLINE</source><source>Springer Online Journals Complete</source><creator>Suzuki, Hidekazu ; Hirashima, Tomonori ; Kobayashi, Masashi ; Okamoto, Norio ; Matsuura, Yuka ; Tamiya, Motohiro ; Morishita, Naoko ; Okafuji, Kohei ; Shiroyama, Takayuki ; Morimura, Osamu ; Morita, Satomu ; Kawase, Ichiro</creator><creatorcontrib>Suzuki, Hidekazu ; Hirashima, Tomonori ; Kobayashi, Masashi ; Okamoto, Norio ; Matsuura, Yuka ; Tamiya, Motohiro ; Morishita, Naoko ; Okafuji, Kohei ; Shiroyama, Takayuki ; Morimura, Osamu ; Morita, Satomu ; Kawase, Ichiro</creatorcontrib><description>Purpose
Patients with incurable lung cancer often receive palliative care. Hyperactive delirium is a burden not only for the patient’s family but also for caregivers. There are no reports describing the risk factors for delirium among lung cancer patients. The present study investigated the frequency of incidence and risk factors for hyperactive delirium among end-stage lung cancer patients.
Methods
Patients who died of lung cancer in our institute from January 2010 to December 2010 were retrospectively investigated. Information was obtained from medical records, and patients who developed hyperactive delirium (delirium group, group D) were compared with patients who did not (control group, group C) based on clinical and laboratory data.
Results
A total of 146 patients (median age, 70 years; 80 % male) died of lung cancer. Thirty-one (21.2 %) patients developed hyperactive delirium. Sex (
P
= 0.0093) and pneumonia (
P
= 0.023) were statistically significant variables in univariate analysis. Pneumonia occurred in 27.4 % of all patients. The incidence of pneumonia was 45.2 % in group D and 22 % in group C. Only pneumonia (odds ratio, 2.89; 95 % confidence interval, 1.22–6.85;
P
= 0.016) was identified as a significant factor for predicting hyperactive delirium in multivariate analysis.
Conclusions
Pneumonia was identified as a significant risk factor for the development of hyperactive delirium among end-stage lung cancer patients.</description><identifier>ISSN: 0941-4355</identifier><identifier>EISSN: 1433-7339</identifier><identifier>DOI: 10.1007/s00520-012-1522-8</identifier><identifier>PMID: 22710844</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer-Verlag</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Bacterial pneumonia ; Cancer patients ; Care and treatment ; Case-Control Studies ; Comparative analysis ; Delirium ; Delirium - epidemiology ; Delirium - prevention & control ; Female ; Humans ; Incidence ; Japan - epidemiology ; Logistic Models ; Lung cancer ; Lung Neoplasms - epidemiology ; Male ; Medical records ; Medicine ; Medicine & Public Health ; Middle Aged ; Multivariate Analysis ; Nursing ; Nursing Research ; Oncology ; Original Article ; Pain Medicine ; Palliative Care ; Pneumonia ; Pneumonia - epidemiology ; Psychomotor Agitation - epidemiology ; Psychomotor Agitation - prevention & control ; Rehabilitation Medicine ; Retrospective Studies ; Risk Factors</subject><ispartof>Supportive care in cancer, 2013-01, Vol.21 (1), p.281-285</ispartof><rights>Springer-Verlag 2012</rights><rights>COPYRIGHT 2013 Springer</rights><rights>Springer-Verlag Berlin Heidelberg 2013</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c505t-bfe7b4cd21934d36e4b61bdc1a6d91e79f73272142417ee1c7a20b6215021b4e3</citedby><cites>FETCH-LOGICAL-c505t-bfe7b4cd21934d36e4b61bdc1a6d91e79f73272142417ee1c7a20b6215021b4e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00520-012-1522-8$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00520-012-1522-8$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>315,781,785,27929,27930,41493,42562,51324</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22710844$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Suzuki, Hidekazu</creatorcontrib><creatorcontrib>Hirashima, Tomonori</creatorcontrib><creatorcontrib>Kobayashi, Masashi</creatorcontrib><creatorcontrib>Okamoto, Norio</creatorcontrib><creatorcontrib>Matsuura, Yuka</creatorcontrib><creatorcontrib>Tamiya, Motohiro</creatorcontrib><creatorcontrib>Morishita, Naoko</creatorcontrib><creatorcontrib>Okafuji, Kohei</creatorcontrib><creatorcontrib>Shiroyama, Takayuki</creatorcontrib><creatorcontrib>Morimura, Osamu</creatorcontrib><creatorcontrib>Morita, Satomu</creatorcontrib><creatorcontrib>Kawase, Ichiro</creatorcontrib><title>Impact of pneumonia on hyperactive delirium in end-stage lung cancer patients</title><title>Supportive care in cancer</title><addtitle>Support Care Cancer</addtitle><addtitle>Support Care Cancer</addtitle><description>Purpose
Patients with incurable lung cancer often receive palliative care. Hyperactive delirium is a burden not only for the patient’s family but also for caregivers. There are no reports describing the risk factors for delirium among lung cancer patients. The present study investigated the frequency of incidence and risk factors for hyperactive delirium among end-stage lung cancer patients.
Methods
Patients who died of lung cancer in our institute from January 2010 to December 2010 were retrospectively investigated. Information was obtained from medical records, and patients who developed hyperactive delirium (delirium group, group D) were compared with patients who did not (control group, group C) based on clinical and laboratory data.
Results
A total of 146 patients (median age, 70 years; 80 % male) died of lung cancer. Thirty-one (21.2 %) patients developed hyperactive delirium. Sex (
P
= 0.0093) and pneumonia (
P
= 0.023) were statistically significant variables in univariate analysis. Pneumonia occurred in 27.4 % of all patients. The incidence of pneumonia was 45.2 % in group D and 22 % in group C. Only pneumonia (odds ratio, 2.89; 95 % confidence interval, 1.22–6.85;
P
= 0.016) was identified as a significant factor for predicting hyperactive delirium in multivariate analysis.
Conclusions
Pneumonia was identified as a significant risk factor for the development of hyperactive delirium among end-stage lung cancer patients.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Bacterial pneumonia</subject><subject>Cancer patients</subject><subject>Care and treatment</subject><subject>Case-Control Studies</subject><subject>Comparative analysis</subject><subject>Delirium</subject><subject>Delirium - epidemiology</subject><subject>Delirium - prevention & control</subject><subject>Female</subject><subject>Humans</subject><subject>Incidence</subject><subject>Japan - epidemiology</subject><subject>Logistic Models</subject><subject>Lung cancer</subject><subject>Lung Neoplasms - epidemiology</subject><subject>Male</subject><subject>Medical records</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Nursing</subject><subject>Nursing Research</subject><subject>Oncology</subject><subject>Original Article</subject><subject>Pain Medicine</subject><subject>Palliative Care</subject><subject>Pneumonia</subject><subject>Pneumonia - epidemiology</subject><subject>Psychomotor Agitation - epidemiology</subject><subject>Psychomotor Agitation - prevention & control</subject><subject>Rehabilitation Medicine</subject><subject>Retrospective Studies</subject><subject>Risk Factors</subject><issn>0941-4355</issn><issn>1433-7339</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNp1kUtr3TAQhUVpaG7T_oBuiqCbbpRo9LSXIfQRSMkmXQtZHt8q2LIr2YX8--py0yctWgxovnOYmUPIK-DnwLm9KJxrwRkHwUALwZonZAdKSmalbJ-SHW8VMCW1PiXPS7nnHKzV4hk5FcICb5TakU_X0-LDSueBLgm3aU7R0znRLw8L5tqI35D2OMYct4nGRDH1rKx-j3Tc0p4GnwJmuvg1YlrLC3Iy-LHgy8d6Rj6_f3d39ZHd3H64vrq8YUFzvbJuQNup0AtopeqlQdUZ6PoA3vQtoG0HK4UVoIQCiwjBesE7I0BzAZ1CeUbeHn2XPH_dsKxuiiXgOPqE81YcCAGNbmQrK_rmL_R-3nKq01XKmHotbuwvau9HdDEN81q3P5i6SylNo2TTmkqd_4Oqr8cphjnhEOv_HwI4CkKeS8k4uCXHyecHB9wdInTHCF2N0B0idE3VvH4ceOsm7H8qfmRWAXEESm2lPebfNvqv63cq9aNS</recordid><startdate>20130101</startdate><enddate>20130101</enddate><creator>Suzuki, Hidekazu</creator><creator>Hirashima, Tomonori</creator><creator>Kobayashi, Masashi</creator><creator>Okamoto, Norio</creator><creator>Matsuura, Yuka</creator><creator>Tamiya, Motohiro</creator><creator>Morishita, Naoko</creator><creator>Okafuji, Kohei</creator><creator>Shiroyama, Takayuki</creator><creator>Morimura, Osamu</creator><creator>Morita, Satomu</creator><creator>Kawase, Ichiro</creator><general>Springer-Verlag</general><general>Springer</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88J</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HEHIP</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M2R</scope><scope>M2S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope></search><sort><creationdate>20130101</creationdate><title>Impact of pneumonia on hyperactive delirium in end-stage lung cancer patients</title><author>Suzuki, Hidekazu ; Hirashima, Tomonori ; Kobayashi, Masashi ; Okamoto, Norio ; Matsuura, Yuka ; Tamiya, Motohiro ; Morishita, Naoko ; Okafuji, Kohei ; Shiroyama, Takayuki ; Morimura, Osamu ; Morita, Satomu ; Kawase, Ichiro</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c505t-bfe7b4cd21934d36e4b61bdc1a6d91e79f73272142417ee1c7a20b6215021b4e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Bacterial pneumonia</topic><topic>Cancer patients</topic><topic>Care and treatment</topic><topic>Case-Control Studies</topic><topic>Comparative analysis</topic><topic>Delirium</topic><topic>Delirium - epidemiology</topic><topic>Delirium - prevention & control</topic><topic>Female</topic><topic>Humans</topic><topic>Incidence</topic><topic>Japan - epidemiology</topic><topic>Logistic Models</topic><topic>Lung cancer</topic><topic>Lung Neoplasms - epidemiology</topic><topic>Male</topic><topic>Medical records</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Nursing</topic><topic>Nursing Research</topic><topic>Oncology</topic><topic>Original Article</topic><topic>Pain Medicine</topic><topic>Palliative Care</topic><topic>Pneumonia</topic><topic>Pneumonia - epidemiology</topic><topic>Psychomotor Agitation - epidemiology</topic><topic>Psychomotor Agitation - prevention & control</topic><topic>Rehabilitation Medicine</topic><topic>Retrospective Studies</topic><topic>Risk Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Suzuki, Hidekazu</creatorcontrib><creatorcontrib>Hirashima, Tomonori</creatorcontrib><creatorcontrib>Kobayashi, Masashi</creatorcontrib><creatorcontrib>Okamoto, Norio</creatorcontrib><creatorcontrib>Matsuura, Yuka</creatorcontrib><creatorcontrib>Tamiya, Motohiro</creatorcontrib><creatorcontrib>Morishita, Naoko</creatorcontrib><creatorcontrib>Okafuji, Kohei</creatorcontrib><creatorcontrib>Shiroyama, Takayuki</creatorcontrib><creatorcontrib>Morimura, Osamu</creatorcontrib><creatorcontrib>Morita, Satomu</creatorcontrib><creatorcontrib>Kawase, Ichiro</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Social Sciences Premium Collection</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Social Science Premium Collection</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Sociology Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Social Science Database</collection><collection>Sociology Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Supportive care in cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Suzuki, Hidekazu</au><au>Hirashima, Tomonori</au><au>Kobayashi, Masashi</au><au>Okamoto, Norio</au><au>Matsuura, Yuka</au><au>Tamiya, Motohiro</au><au>Morishita, Naoko</au><au>Okafuji, Kohei</au><au>Shiroyama, Takayuki</au><au>Morimura, Osamu</au><au>Morita, Satomu</au><au>Kawase, Ichiro</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Impact of pneumonia on hyperactive delirium in end-stage lung cancer patients</atitle><jtitle>Supportive care in cancer</jtitle><stitle>Support Care Cancer</stitle><addtitle>Support Care Cancer</addtitle><date>2013-01-01</date><risdate>2013</risdate><volume>21</volume><issue>1</issue><spage>281</spage><epage>285</epage><pages>281-285</pages><issn>0941-4355</issn><eissn>1433-7339</eissn><abstract>Purpose
Patients with incurable lung cancer often receive palliative care. Hyperactive delirium is a burden not only for the patient’s family but also for caregivers. There are no reports describing the risk factors for delirium among lung cancer patients. The present study investigated the frequency of incidence and risk factors for hyperactive delirium among end-stage lung cancer patients.
Methods
Patients who died of lung cancer in our institute from January 2010 to December 2010 were retrospectively investigated. Information was obtained from medical records, and patients who developed hyperactive delirium (delirium group, group D) were compared with patients who did not (control group, group C) based on clinical and laboratory data.
Results
A total of 146 patients (median age, 70 years; 80 % male) died of lung cancer. Thirty-one (21.2 %) patients developed hyperactive delirium. Sex (
P
= 0.0093) and pneumonia (
P
= 0.023) were statistically significant variables in univariate analysis. Pneumonia occurred in 27.4 % of all patients. The incidence of pneumonia was 45.2 % in group D and 22 % in group C. Only pneumonia (odds ratio, 2.89; 95 % confidence interval, 1.22–6.85;
P
= 0.016) was identified as a significant factor for predicting hyperactive delirium in multivariate analysis.
Conclusions
Pneumonia was identified as a significant risk factor for the development of hyperactive delirium among end-stage lung cancer patients.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer-Verlag</pub><pmid>22710844</pmid><doi>10.1007/s00520-012-1522-8</doi><tpages>5</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0941-4355 |
| ispartof | Supportive care in cancer, 2013-01, Vol.21 (1), p.281-285 |
| issn | 0941-4355 1433-7339 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1221858393 |
| source | MEDLINE; Springer Online Journals Complete |
| subjects | Adult Aged Aged, 80 and over Bacterial pneumonia Cancer patients Care and treatment Case-Control Studies Comparative analysis Delirium Delirium - epidemiology Delirium - prevention & control Female Humans Incidence Japan - epidemiology Logistic Models Lung cancer Lung Neoplasms - epidemiology Male Medical records Medicine Medicine & Public Health Middle Aged Multivariate Analysis Nursing Nursing Research Oncology Original Article Pain Medicine Palliative Care Pneumonia Pneumonia - epidemiology Psychomotor Agitation - epidemiology Psychomotor Agitation - prevention & control Rehabilitation Medicine Retrospective Studies Risk Factors |
| title | Impact of pneumonia on hyperactive delirium in end-stage lung cancer patients |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-15T04%3A49%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Impact%20of%20pneumonia%20on%20hyperactive%20delirium%20in%20end-stage%20lung%20cancer%20patients&rft.jtitle=Supportive%20care%20in%20cancer&rft.au=Suzuki,%20Hidekazu&rft.date=2013-01-01&rft.volume=21&rft.issue=1&rft.spage=281&rft.epage=285&rft.pages=281-285&rft.issn=0941-4355&rft.eissn=1433-7339&rft_id=info:doi/10.1007/s00520-012-1522-8&rft_dat=%3Cgale_proqu%3EA336843896%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1266433067&rft_id=info:pmid/22710844&rft_galeid=A336843896&rfr_iscdi=true |